Lilly To Invest $450 M in North Carolina Mfg Site
By

By
Eli Lilly and Company has announced plans to invest an additional $450 million to expand its manufacturing site in Research Triangle Park, North Carolina. The expansion includes additional parenteral filling,…

EU Officials Address Shortages of Antibiotics in the EU
By

By
European Union (EU) officials are moving to address recent shortages of  antibiotics, particularly amoxicillin, in the EU and outlined recent action to address manufacturing and supply issues.   “Shortages of medicines…

Supplier News: Catalent, Experic, Stevanato & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Experic, Stevanato, and Colorcon.  Biologics Manufacturing * Catalent Opens Plasmid DNA Mfg Facility Formulation Development/Drug Product Manufacturing * Experic Adds New Analytical Lab * Colorcon…

Global Briefs: Takeda, Sandoz, Astellas, Vir & More
By

By
A roundup of news from Takeda, Hutchmed, Torrent Pharmaceuticals, Sandoz, Astellas, Vir Biotechnology, Sanofi and CytoReason. Highlights below.   * Takeda, Hutchmed in $1.13-Bn Licensing Pact for Cancer Drug   * FDA…

Hear from Industry Leaders at DCAT Week on How to Optimize Supply Practices and Mitigate Risk
By

By
Dealing with recent market volatility (inflationary pressures, supply-chain disruptions, and geopolitical uncertainty) has been the number one issue facing the industry as it grapples with escalating raw materials costs, actual…

Pharma Industry Outlook: The Market Info You Need to Know: Only at DCAT Week
By

By
The all-important question for both bio/pharma companies and their suppliers is how will the industry perform in 2023 and the near term?   DCAT Week’s flagship program, Pharma Industry Outlook, will…

Pfizer To Acquire Biomanufacturing Facility from CDMO Abzena
By

By
Pfizer has agreed to acquire a biomanufacturing facility in Sanford, North Carolina from Abzena, a San Diego, California-based CDMO of biologics and antibody drug conjugates,   The new Sanford, North Carolina…

Supplier News: Cambrex, Lonza, Forcyte Bio & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Cambrex, Snapdragon Chemistry, Sai Life Sciences, Lonza, Forcyte Bio, ILC Dover, Upperton Bio, National Resilience and Eurofins CDMO Alphora.   Chemicals/Chemical API Manufacturing *…

M&A News: AstraZeneca & Sun Pharma
By

By
The latest news on mergers and acquisitions featuring AstraZeneca/Neogene Therapeutics and Sun Pharmaceuticals/Concert Pharmaceuticals. Highlights below.  * AstraZeneca Acquires Neogene Therapeutics in $320-M Deal * Sun Pharma To Acquire Concert Pharmaceuticals…

Global Briefs: J&J, Pfizer & Biocon
By

By
A roundup of news from J&J, Pfizer, and Biocon Biologics. Highlights below.   * FDA Issues Complete Response Letter to Biocon Biologics* J&J Discontinues HIV Vaccine Phase III Trial* Pfizer Expands…